Skip to main content
. 2021 Sep 27;12:707189. doi: 10.3389/fphys.2021.707189

Figure 8.

Figure 8

The clinical PV activation flow metric is significantly different for PVI responder and non-responder cases. (A) Clinical PV activation flow (%) pre-ablation was significantly higher for PVI responder than PVI non-responder cases (PVI responder: 16.3% vs. non-responder: 3.71%, p = 0.035). (B) LA cycle length was not significantly different between groups (Wilcoxon signed-rank). (C) RA cycle length was not significantly different between groups.